Gyre Therapeutics annual gross profit
2009
2022
2023
2024
2025
Gyre Therapeutics Gross Profit Growth & History (GYRE)
Gyre Therapeutics's gross profit was $111.2M for fiscal 2025.
View full Gyre Therapeutics company overviewGyre Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $111.2M | $9.3M | +9.13% |
| 2024 | 2024-12-31 | $101.9M | −$6.9M | −6.38% |
| 2023 | 2023-12-31 | $108.8M | $11.3M | +11.61% |
| 2022 | 2022-12-31 | $97.5M | — | — |
| 2009 | 2009-12-31 | $24.4M | — | — |
Gyre Therapeutics quarterly gross profit
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26.9M | $1.3M | +4.98% |
| Q1 2026 | 2026-03-31 | $21.3M | $128,000 | +0.60% |
| Q4 2025 | 2025-12-31 | $35.5M | $8.8M | +32.80% |
| Q3 2025 | 2025-09-30 | $28.9M | $4.4M | +17.96% |
| Q2 2025 | 2025-06-30 | $25.6M | $1.2M | +4.76% |
| Q1 2025 | 2025-03-31 | $21.2M | −$5.0M | −19.20% |
| Q4 2024 | 2024-12-31 | $26.7M | $797,000 | +3.08% |
| Q3 2024 | 2024-09-30 | $24.5M | −$6.3M | −20.51% |
| Q2 2024 | 2024-06-30 | $24.5M | −$3.8M | −13.44% |
| Q1 2024 | 2024-03-31 | $26.2M | $2.4M | +10.03% |
| Q4 2023 | 2023-12-31 | $25.9M | — | — |
| Q3 2023 | 2023-09-30 | $30.9M | — | — |
| Q2 2023 | 2023-06-30 | $28.3M | — | — |
| Q1 2023 | 2023-03-31 | $23.8M | — | — |
Gyre Therapeutics gross profit trends
Between the periods ended 2009-12-31 and 2025-12-31, Gyre Therapeutics's gross profit increased from $24.4M to $111.2M, a change of $86.8M. The latest reported quarter, Q2 2026, shows $26.9M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gyre Therapeutics source filings ↗